Back to Search
LETO QUARLES, M.D.
M.D.
Family Medicine Physician
NPI: 1811917883IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
45461(CO)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF UTAH SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?
PMID 19534362·Nephrol News Issues·2009
6-review
Dose-dependent effects of Runx2 on bone development.
PMID 19419310·J Bone Miner Res·2009
7-preclinical
Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?
PMID 18957950·Nat Clin Pract Nephrol·2009
6-review
Novel regulators of Fgf23 expression and mineralization in Hyp bone.
PMID 19556340·Mol Endocrinol·2009
7-preclinical
Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets.
PMID 18256372·Clin J Am Soc Nephrol·2008
3-trial
GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome.
PMID 19050760·PLoS One·2008
7-preclinical
Polycystin-1 regulates skeletogenesis through stimulation of the osteoblast-specific transcription factor RUNX2-II.
PMID 18321855·J Biol Chem·2008
7-preclinical
Pathogenic role of Fgf23 in Dmp1-null mice.
PMID 18559986·Am J Physiol Endocrinol Metab·2008
7-preclinical
Field trial and modeling of uptake rates of in situ lipid-free polyethylene membrane passive sampler.
PMID 18605575·Environ Sci Technol·2008
8-other
Inhibition of adipocyte differentiation by phytoestrogen genistein through a potential downregulation of extracellular signal-regulated kinases 1/2 activity.
PMID 18384126·J Cell Biochem·2008
7-preclinical
FGFR3 and FGFR4 do not mediate renal effects of FGF23.
PMID 18753255·J Am Soc Nephrol·2008
7-preclinical
Endocrine functions of bone in mineral metabolism regulation.
PMID 19033649·J Clin Invest·2008
6-review
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics.
PMID 17568787·Kidney Int·2008
6-review
Parathyroid-specific interaction of the calcium-sensing receptor and G alpha q.
PMID 18813283·Kidney Int·2008
7-preclinical
Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation.
PMID 17689939·Phytomedicine·2007
8-other
Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice.
PMID 17554146·J Am Soc Nephrol·2007
7-preclinical
Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
PMID 17565275·Curr Opin Nephrol Hypertens·2007
6-review
RNA interference and its application in bone-related diseases.
PMID 17686458·Biochem Biophys Res Commun·2007
6-review
Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
PMID 17848631·Am J Physiol Endocrinol Metab·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 1755 48TH ST, SUITE 200
BOULDER, CO 80301 - Phone
- (303) 494-5263
Quick Facts
- NPI
- 1811917883
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 3
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile